organism: Xenopus laevis
attributes.tag: isolate
attributes.value: SPL_Caps_rep5
attributes.tag: dev_stage
attributes.value: NF12.5
attributes.tag: collection_date
attributes.value: not applicable
attributes.tag: geo_loc_name
attributes.value: not applicable
attributes.tag: sex
attributes.value: pooled male and female
attributes.tag: tissue
attributes.value: Neuralised animal caps
attributes.tag: treatment
attributes.value: 2-cell stage embryos were co-injected at the animal pole of both blastomeres with noggin mRNA and either Mettl9 or Control morpholinos (each blastomere received 23 pg of noggin mRNA+10 ng of MO). At stage 9, Animal Capss were dissected from injected embryos and grown in 1X MBS with gentamycin (at 50 mg/ml final concentration) until sibling embryos reached stage NF12.5
attributes.tag: BioSampleModel
attributes.value: Model organism or animal